Schnitzler syndrome: A review of literature, the authors' observation, and experience with the interleukin-1 inhibitor canakinumab

被引：2
|
作者：
Salugina, S. O. [1 ]
Gorodetsky, V. R. [1 ]
Fedorov, E. S. [1 ]
Lopatina, N. E. [1 ]
Evsikova, M. D. [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2017年 / 89卷 / 11期
关键词：
autoinflammatory diseases; Schnitzler syndrome; therapy; IL-1; inhibitors; canakinumab; CHRONIC URTICARIA; FOLLOW-UP; ANAKINRA; MACROGLOBULINEMIA; GAMMOPATHY; DISEASE; SAFETY;
D O I：
10.17116/terarkh20178911111-115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors' own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor canakinumab to treat this disease.
引用
收藏
页码：111 / 115
页数：7
相关论文
共 50 条
  • [1] Interleukin-1 Beta It Is: High Efficacy of Canakinumab In Schnitzler Syndrome.
    de Koning, Heleen D.
    Schalkwijk, Joost
    van der Ven-Jongekrijg, Johanna
    Stoffels, Monique
    van der Meer, Jos W. M.
    Simon, Anna
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S952 - S953
  • [2] Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review
    Betrains, A.
    Staels, F.
    Vanderschueren, S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 636 - 642
  • [3] Interleukin-1 Receptor Antagonist treatment in Schnitzler syndrome
    Land, M.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A68 - A68
  • [4] ANALYSIS OF INTERLEUKIN-1β INHIBITOR (CANAKINUMAB) IMPACT ON ENDOTHELIAL DYSFUNCTION
    Eliseev, M.
    Zhelyabina, O.
    Vladimirov, S.
    Markelova, E.
    Novikova, D.
    Korsakova, O.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1183 - 1183
  • [5] Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
    Soennichsen, Astrid
    Saulite, Ieva
    Mangana, Johanna
    Kerl, Katrin
    Mehra, Tarun
    Desislava, Ignatova
    Chang, Yun-Tsan
    Petrausch, Ulf
    Schmid-Grendelmeier, Peter
    Hoetzenecker, Wolfram
    Cozzio, Antonio
    Guenova, Emmanuella
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) : 436 - 438
  • [6] Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome
    Migliorini, P.
    Italiani, P.
    Pratesi, F.
    Puxeddu, I
    Boraschi, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (03) : 235 - 238
  • [7] The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome
    de Koning, Heleen D.
    Schalkwijk, Joost
    Stoffels, Monique
    Jongekrijg, Johanna
    Jacobs, Joannes F. M.
    Verwiel, Eugene
    Koenen, Hans J. P. M.
    Preijers, Frank
    Holzinger, Dirk
    Joosten, Irma
    van der Meer, Jos W. M.
    Simon, Anna
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [8] The role of interleukin-1 beta in the pathophysiology of Schnitzler’s syndrome
    Heleen D. de Koning
    Joost Schalkwijk
    Monique Stoffels
    Johanna Jongekrijg
    Joannes F. M. Jacobs
    Eugène Verwiel
    Hans J. P. M. Koenen
    Frank Preijers
    Dirk Holzinger
    Irma Joosten
    Jos W. M. van der Meer
    Anna Simon
    Arthritis Research & Therapy, 17
  • [9] EXPERIENCE WITH INTERLEUKIN-1 INHIBITOR CANAKINUMAB IN AUTO-INFLAMMATORY DISEASES AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL PRACTICE
    Salugina, S. O.
    Kaleda, M.
    Fedorov, E.
    Nikishina, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 622 - 622
  • [10] Efficacy and safety of the anti-interleukin-1 beta antibody canakinumab in patients with Schnitzler's syndrome
    de Koning, H.
    Schalkwijk, J.
    van der Ven-Jongekrijg, J.
    Stoffels, M.
    van der Meer, J.
    Simon, A.
    ALLERGY, 2012, 67 : 106 - 106
12345